Life as a Chief Editor in Nature Communications
September 25 @ 13:00 – 14:00
Are you wondering what comes next after your postdoc? Our lunch talk series Career Perspectives: Beyond the Postdoc offers insights into diverse career opportunities beyond postdoctoral research.
In our next session, we are pleased to welcome Dr. Stephanie Koo, Chief Editor for Cancer at Nature Communications and Advisory Editor at npj Breast Cancer.
Dr. Koo earned her PhD in Oncology and Cancer Biology from the National University of Singapore. She began her postdoctoral path at A*STAR (Agency for Science, Technology and Research) in Singapore, then moved to London to continue her research at Imperial College London and King’s College London. After nearly eight years as a postdoc, she transitioned into scientific publishing, starting as an Associate Editor at Springer Nature Group. Over the past eight years, she has continued to grow within the company, and this November marks her second year as Chief Editor.
In this lunch talk, we will explore the key skills and experiences from Dr. Koo’s academic journey that prepared her for a successful career in scientific publishing. She will also share insights into the main responsibilities and challenges of being a Scientific Editor. The session will conclude with time for questions and open discussion.
Join us for an engaging conversation on transitioning from academia to scientific publishing and discover more about this exciting path within science communication.
About Stephanie Koo
Dr. Stephanie Koo graduated with a degree in Biochemistry in 2004 and obtained her PhD in Oncology and Cancer Biology in 2009 from the National University of Singapore. That same year, she began her postdoctoral path at A*STAR (Agency for Science, Technology and Research) in Singapore, working on cancer glycobiology. In 2011, she moved to London to continue her research as a Postdoctoral Researcher at Imperial College London, focusing on the molecular mechanisms of forkhead box proteins in breast cancer progression and treatment for nearly two and a half years. Her final postdoctoral position before transitioning into scientific publishing was at King’s College London, where she studied the roles of TAO kinases in mitosis and anti-cancer treatment. Since 2017, Dr. Koo has been working at Springer Nature Group. She began as an Associate Editor and progressed to Senior Editor and Team Manager at Nature Communications. In 2023, she was appointed Advisory Editor for npj Breast Cancer and Chief Editor for Cancer at Nature Communications.
